Pablo Ledesma del Pozo, managing director at PharmaBrand, discusses the company’s ambition to equal the business model of a multinational companies in the foreseeable future by commercializing their products as well as opening fully-integrated affiliates in neighboring countries, such as Chile, Peru, Bolivia and Central American countries.
Pablo, you have an extensive pharma career in international multinational companies. What led you to pursue this leadership position at Pharmabrand in 2011?
"While we produce branded generic drugs, our business model resembles that of multinational pharmaceutical companies and so does the quality of our products."
